A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Food Effects of XH-S004 Single and Multiple Ascending Doses in Healthy Volunteers
Latest Information Update: 14 Feb 2024
At a glance
- Drugs XH S004 (Primary)
- Indications Bronchiectasis
- Focus Adverse reactions
- Sponsors S-Infinity Pharmaceuticals
Most Recent Events
- 08 Feb 2024 New trial record